Transvaginal sonography as a screening method for the detection of early ovarian cancer

Gynecologic Oncology
Paul D DePriestJohn R van Nagell

Abstract

From December 1987 to December 1993, 6470 women underwent screening with transvaginal sonography (TVS) as part of the University of Kentucky Ovarian Cancer Screening Project. Two groups of women were eligible to participate in this investigation: (i) asymptomatic postmenopausal patients or patients >50 years of age, and (ii) asymptomatic women >30 years of age with a family history of ovarian cancer. Ovarian volume was calculated using the prolate ellipsoid formula (length x height x width x 0.523). An abnormal sonogram was defined by (1) an ovarian volume >10 cm3 in postmenopausal women or >20 cm3 in premenopausal women, and (2) a papillary or complex tissue projection into a cystic ovarian tumor. All women with an abnormal TVS had a repeat sonogram in 4-6 weeks. Patients with persistently abnormal scans had a serum CA-125 determination, tumor morphology indexing, and color Doppler sonography. Ninety patients (1.4%) with a persisting abnormality on TVS underwent exploratory laparotomy or laparoscopy for tumor removal. Thirty-seven patients had serous cystadenomas and six had primary ovarian cancers. Five patients had Stage IA ovarian cancer and one patient had Stage IIIB disease. Only one of the ovarian cancer patients had a p...Continue Reading

References

Oct 14, 1992·JAMA : the Journal of the American Medical Association·C I AmosP Hartge
Nov 1, 1991·Gynecologic Oncology·T H BourneW P Collins
Mar 1, 1991·Cancer·H T LynchB A Ponder
Oct 1, 1990·Gynecologic Oncology·R V HigginsR J Kryscio
Dec 2, 1989·BMJ : British Medical Journal·S CampbellW P Collins
Apr 6, 1988·Journal of the National Cancer Institute·W J MannM Loesch

❮ Previous
Next ❯

Citations

Sep 8, 2000·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·E J PavlikJ R Van Nagell
Sep 8, 2000·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·U Menon, I Jacobs
Mar 24, 2009·Obstetrics and Gynecology·Edward PartridgeUNKNOWN PLCO Project Team
Oct 6, 2004·World Journal of Surgical Oncology·Karsten Münstedt, Folker E Franke
Sep 19, 2000·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Y Y JeongH K Kang
May 27, 2006·Journal of Women's Health·Christie R EhemanMona Saraiya
Oct 12, 2004·Mayo Clinic Proceedings·Barbara P YawnPeter C Wollan
Aug 24, 1999·Seminars in Ultrasound, CT, and MR·P A Dubbins, B Subba
Oct 5, 2006·Critical Reviews in Oncology/hematology·Nicoletta ColomboIgnace Vergote
Feb 15, 2001·The Journal of the American Association of Gynecologic Laparoscopists·L MettlerK Semm
Mar 12, 2013·Medical Hypotheses·Laura Elise HorvathKimberly Jones
Jun 1, 2000·Gynecologic Oncology·E J PavlikJ R van Nagell
Mar 25, 2017·Diagnostics·Robert M OreEdward J Pavlik
Oct 25, 2000·The Journal of the American Association of Gynecologic Laparoscopists·P A Argenta, F Nezhat
Aug 24, 2013·Obstetrics and Gynecology·Edward J PavlikJohn R van Nagell
Feb 7, 2004·Molecular & Cellular Proteomics : MCP·Ian J Jacobs, Usha Menon
Oct 3, 1999·Seminars in Surgical Oncology·T C Randall, S C Rubin
Mar 3, 2004·Journal of Clinical Ultrasound : JCU·Ilan BruchimRonnie Tepper
Sep 27, 2005·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·L SavelliB Cacciatore
May 11, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Edward J Pavlik, John R van Nagell
Jul 26, 2002·Expert Review of Molecular Diagnostics·Ali M ArdekaniEmanuel F Petricoin
Jul 22, 2006·The Journal of Family Planning and Reproductive Health Care·Karim Elmasry
Aug 23, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·H YoonD Tomé
Mar 4, 1998·Current Opinion in Obstetrics & Gynecology·W P CollinsS Campbell
Jan 12, 2000·Cancer·A BerchuckP A Futreal
Feb 4, 2010·Molecular Diagnosis & Therapy·Christine S Walsh, Beth Y Karlan
May 9, 2002·Hospital Medicine·Farhad Alexander-SefreIan J Jacobs
Nov 15, 2002·Cancer Detection and Prevention·Chad M MichenerElise C Kohn
Dec 10, 1999·The Medical Clinics of North America·K M Zanotti, A W Kennedy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.